Advances in Pathogenesis and Treatment of Glomerulonephritis
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Urology & Nephrology".
Deadline for manuscript submissions: closed (1 December 2023) | Viewed by 14564
Special Issue Editor
Interests: pediatric nephrology; pediatric rheumatology; clinical nephrology; glomerulonephritis; nephrotic syndrome; rare diseases; autoimmune diseases; autoinflammatory diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Glomerulonephritis is the main cause of rapid evolution towards chronic renal failure, in case of non-diagnosis and treatment. Glomerulonephritis can be primary or secondary to various systemic diseases, in particular vasculitis and connective tissue diseases. Its pathogenesis is therefore, in the majority of cases, immunological. In recent years, there has been progress on the pathogenetic knowledge of various glomerulonephritis: membranous nephropathy, IgA nephropathy, C3 glomerulonephritis and nephrotic syndrome. Further discoveries have occurred in the genetics of hereditary nephritis. This recent pathogenetic knowledge has led to the use of new therapeutic protocols, also making use of biological drugs, with excellent efficacy and few side effects.
This Special Issue will deal with several aspects of prognostic risk factors, pathogenesis and treatment of glomerulonephritis.
Dr. Giovanni Conti
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glomerulonephritis
- nephrotic syndrome
- membranous nephropathy
- IgA nephropathy
- hereditary nephritis
- vasculitis
- systemic lupus erythematosus
- pathogenesis
- therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.